IPO

Sunrest Lifescience Limited IPO

NSE SME

Listed On: Nov 20, 2023 at ₹ 84.0

₹ 268800 /3200 Shares
*Min Investment

Check Allotment

07 Nov, 2023

Open Date

09 Nov, 2023

Close Date

15 Nov, 2023

Allotment Date

20 Nov, 2023

Listing Date
Sunrest Lifescience Limited IPO Issue Details
  • Issue Price ₹84 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price 1,291,200 shares(aggregating up to ₹10.85 Cr)
  • Listing at NSE SME
  • List Price 84.0
  • Listing Date 2023-11-20
  • Lead Manager Mark Corporate Advisors Private Limited
  • Registrar Skyline Financial Services Private Ltd
Sunrest Lifescience Limited IPO Details
  • Retail Portion 50%
Sunrest Lifescience Limited IPO Documents
Sunrest Lifescience Limited IPO Details


Sunrest Lifescience Limited IPO is an SME IPO, priced at ₹84 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform.

The IPO bidding window is open from Nov 7, 2023 to Nov 9, 2023. The allotment is expected to be finalized on Nov 15, 2023, and the tentative listing date is Nov 20, 2023.


The registrar of the IPO is Skyline Financial Services Private Ltd, and

Read More
Sunrest Lifescience Limited IPO Subscription Analysis And Details
Retail
65.74x
Total
48.54x
As onQIB / NIIRetailTotal
Shares Offered / Reserved612,800612,8001,225,600
Day 1 07-11-23 06:00 PM
0.62 x5.86 x3.24 x
Day 2 08-11-23 06:00 PM
2.67 x19.88 x11.28 x
Day 3 09-11-23 06:00 PM
29.17 x65.74 x48.54 x
Sunrest Lifescience Limited Valuations
Earnings Per Share (EPS) ₹6.81/-
P/E Ratio 12.33
RoNW 65.59%
Net Asset Value (NAV) - Post Issue ₹N/A/-
Sunrest Lifescience Limited Company Financials
In Lakhs
In Lakh
31-Mar-2331-Mar-2231-Mar-21
Assets1,671.371,301.97948.15
Revenue2,467.052,690.991,694.91
Profit After Tax204.3177.7116.55
About Sunrest Lifescience Limited Company

Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.

The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.

The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.

Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.

With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.

Read More
Sunrest Lifescience Limited - Promoter(s)

Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar.

Pre Issue Share Holding : 100%

Post Issue Share Holding : 69.91%

Sunrest Lifescience Limited IPO - Issue Objectives
1

Meeting Working Capital Requirements

2

General Corporate Purpose

3

Meeting Public Issue Expenses